Targeting cancer stem cells with ALDH1A1-based immunotherapy

par DeLeo, Albert B.
Publié 2012

The p53 saga: Early steps in the development of tumor immunotherapy

par De Leo, Albert B., Appella, Ettore
Publié dans J Immunol (2020)

Development of multi-epitope vaccines targeting wild-type (wt) sequence p53 peptides

par DeLeo, Albert B., Whiteside, Theresa L.
Publié 2008

Relation of cell surface antigens on methylcholanthrene-induced fibrosarcomas to immunoglobulin heavy chain complex variable region-linked T cell interaction molecules

par Flood, Patrick M., DeLeo, Albert B., Old, Lloyd J., Gershon, Richard K.
Publié 1983

CD8+ T cell recognition of polymorphic wild-type sequence p53(65–73) peptides in squamous cell carcinoma of the head and neck

par Andrade Filho, Pedro A., Ito, Daisuke, DeLeo, Albert B., Ferris, Robert L.
Publié 2010

p53 transformation-related protein: Detection by monoclonal antibody in mouse and human cells

par Dippold, Wolfgang G., Jay, Gilbert, DeLeo, Albert B., Khoury, George, Old, Lloyd J.
Publié 1981

Toward the development of multi-epitope p53 cancer vaccines: an in vitro assessment of CD8(+) T-cell responses to HLA class I-restricted wild-type sequence p53 peptides

par Sakakura, Koichi, Chikamatsu, Kazuaki, Furuya, Nobuhiko, Appella, Ettore, Whiteside, Theresa L., DeLeo, Albert B.
Publié 2007

SPONTANEOUS APOPTOSIS OF TUMOR-SPECIFIC TETRAMER(+) CD8(+) T LYMPHOCYTES IN THE PERIPHERAL CIRCULATION OF PATIENTS WITH HEAD AND NECK CANCER

par Albers, Andreas E., Schaefer, Carsten, Visus, Carmen, Gooding, William, DeLeo, Albert B., Whiteside, Theresa L.
Publié 2009

CD4+ T cell responses to HLA-DP5-restricted wild-type sequence p53 peptides in patients with head and neck cancer

par Chikamatsu, Kazuaki, Sakakura, Koichi, Takahashi, Goro, Okamoto, Atsushi, Furuya, Nobuhiko, Whiteside, Theresa L., DeLeo, Albert B., Masuyama, Keisuke
Publié 2009

Targeting cancer stem cells with p53 modulators

par Zhang, Zhan, Liu, Ling, Gomez-Casal, Roberto, Wang, Xinhui, Hayashi, Ryo, Appella, Ettore, Kopelovich, Levy, DeLeo, Albert B.
Publié dans Oncotarget (2016)

Inhibition of soluble tumor necrosis factor prevents chemically-induced carcinogenesis in mice

par Sobo-Vujanovic, Andrea, Vujanovic, Lazar, DeLeo, Albert B, Concha-Benavente, Fernando, Ferris, Robert L, Lin, Yan, Vujanovic, Nikola L
Publié dans Cancer Immunol Res (2016)

Phenotype of p53 wild-type epitope-specific T cells in the circulation of patients with head and neck cancer

par Albers, Andreas E., Qian, Xu, Kaufmann, Andreas M., Mytilineos, Daphne, Ferris, Robert L., Hoffmann, Thomas K., DeLeo, Albert B.
Publié dans Sci Rep (2018)

Identification of Hydroxysteroid (17β) dehydrogenase type 12 (HSD17B12) as a CD8(+) T-cell-defined human tumor antigen of human carcinomas

par Visus, Carmen, Ito, Diasuke, Dhir, Rajiv, Szczepanski, Miroslaw J., Chang, Yoo Jung, Latimer, Jean J., Grant, Stephen G., DeLeo, Albert B.
Publié 2011

17β hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma

par Szajnik, Marta, Szczepanski, Miroslaw J., Elishaev, Esther, Visus, Carmen, Lenzner, Diana, Zabel, Maciej, Glura, Marta, DeLeo, Albert B., Whiteside, Theresa L.
Publié 2012

Induction of autophagy-dependent apoptosis in cancer cells through activation of ER stress: an uncovered anti-cancer mechanism by anti-alcoholism drug disulfiram

par Zhang, Xiao, Hu, Pan, Ding, Shi-Ying, Sun, Ting, Liu, Ling, Han, Shiwei, DeLeo, Albert B, Sadagopan, Ananthan, Guo, Wei, Wang, Xinhui
Publié dans Am J Cancer Res (2019)

Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts

par Yao, Wenhao, Qian, Xu, Ochsenreither, Sebastian, Soldano, Ferrone, DeLeo, Albert B., Sudhoff, Holger, Oppel, Felix, Kuppig, Andreas, Klinghammer, Konrad, Kaufmann, Andreas M., Albers, Andreas E.
Publié dans Cells (2021)

Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram

par Sun, Ting, Yang, Wei, Toprani, Sneh M., Guo, Wei, He, Lile, DeLeo, Albert B., Ferrone, Soldano, Zhang, Gong, Wang, Enwen, Lin, Zunwen, Hu, Pan, Wang, Xinhui
Publié dans Cell Commun Signal (2020)

Correction to: Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram

par Sun, Ting, Yang, Wei, Toprani, Sneh M., Guo, Wei, He, Lile, DeLeo, Albert B., Ferrone, Soldano, Zhang, Gong, Wang, Enwen, Lin, Zunwen, Hu, Pan, Wang, Xinhui
Publié dans Cell Commun Signal (2020)

Identification of a 17β-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide

par Hendrickson, Ronald C., Cicinnati, Vito R., Albers, Andreas, Dworacki, Grzegorz, Gambotto, Andrea, Pagliano, Ornella, Tüting, Thomas, Mayordomo, Jose I., Visus, Carmen, Appella, Ettore, Shabanowitz, Jeffrey, Hunt, Donald F., DeLeo, Albert B.
Publié 2009

Targeting ALDH(bright) human carcinoma initiating cells with ALDH1A1- specific CD8(+) T cells

par Visus, Carmen, Wang, Yangyang, Lozano-Leon, Antonio, Ferris, Robert L., Silver, Susan, Szczepanski, Miroslaw J., Brand, Randall E., Ferrone, Cristina R., Whiteside, Theresa L., Ferrone, Soldano, DeLeo, Albert B., Wang, Xinhui
Publié 2011